APA (7th ed.) Citation

VSSA, A., R, P., S, P., S, G., A, P., M, T., . . . C, H. (2026). Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability. Leukemia, 40(8), 1824. https://doi.org/10.1038/s41375-026-03011-3

Chicago Style (17th ed.) Citation

VSSA, Ayyadevara, et al. "Selective Sensitivity of Ph-like B-cell Acute Lymphoblastic Leukemia to BRG1 Inhibition Identifies a Therapeutic Vulnerability." Leukemia 40, no. 8 (2026): 1824. https://doi.org/10.1038/s41375-026-03011-3.

MLA (9th ed.) Citation

VSSA, Ayyadevara, et al. "Selective Sensitivity of Ph-like B-cell Acute Lymphoblastic Leukemia to BRG1 Inhibition Identifies a Therapeutic Vulnerability." Leukemia, vol. 40, no. 8, 2026, p. 1824, https://doi.org/10.1038/s41375-026-03011-3.